Used as an intermediate in pharmaceutical synthesis, particularly in the production of bioactive molecules and drug candidates. Its structure allows for selective functionalization, making it valuable in constructing complex nitrogen-containing compounds. Commonly employed in the development of protease inhibitors and receptor antagonists due to the stability and reactivity of the pyrrolidine ring. The bromomethyl group enables further alkylation or coupling reactions, facilitating the introduction of the pyrrolidine moiety into larger molecular frameworks. Also utilized in agrochemical research for designing novel active ingredients.